References
- Gerding DN, Olson MM, Peterson LR, et al. Clostridium difficile- associated diarrhea and colitis in adults: a prospective case-controlled epidemiologic study. Arch Intern Med 1986;146(1): 95–100
- Fekety R, McFarland LV, Surawicz CM, et al. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in prospective, randomized, double-blinded trial. Clin Infect Dis 1997;24(3): 324–33
- Larson HE, Price AB, Honour P, et al. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978;1(8073): 1063–6
- Bartlett JG. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994; 18(Suppl 4):S265–72
- Riegler M, Sedivy R, Pothoulakis C, et al. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium mucosa in vitro. J Clin Invest 1995;95(5): 2004–11
- Yassin SF, Young-Fadok TM, Zein NN, et al. Clostridium difficile-associated diarrhea and colitis. Mayo Clin Proc 2001;76(7): 725–30
- Reinke CM, Messick CR. Update on Clostridium difficile-induced colitis, part 1. Am J Hosp Pharm 1994;51(15): 1771–81
- Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Am J Gastroenterol 1997;92(5): 739–50
- Mylonakis E, Ryan ET, Calderwood SB. Clostridium difficile-associated diarrhea: a review. Arch Intern Med 2001;161(4): 525–33
- Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Am J Infect Control 1995;23(2): 87–94
- Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile- associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol 2000;95(11): 3283–5
- Walters BA, Roberts R, Stafford R, et al. Relapse of antibiotic associated colitis: endogenous persistence of Clostridium difficile during vancomycin therapy. Gut 1983;24(3): 206–12
- Tedesco FJ, Gordon D, Forston WC. Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1985;80(11): 867–8
- Tedesco F. Treatment of recurrent antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1982;77(4): 220–1
- Buggy BP, Fekety R, Silva J Jr. Therapy of relapsing Clostridium difficile- associated diarrhea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol 1987;9(2): 155–9
- Pochapin M. The effect of probiotics on Clostridium difficile diarrhea. Am J Gastroenterol 2000;95(1 Suppl):S11–13
- Pothoulakis C, Kelly CP, Joshi MA, et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology 1993;104:1108–15
- McFarland LV, Surawicz CM, Greenberg RN. A randomized placebo- controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 1994;271(24): 1913–8
- Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with lactobacillus GG. (Letter) Lancet 1987; 2(8574): 1519
- Salcedo J, Keates S, Pothoulakis C, et al. Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut 1997;41:366–70
- Leung DY, Kelly CP, Boguniewicz M. Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991;118(4 Pt 1):633–7
- Kim KH, Fekety R, Batts DH, et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 1981;143(1): 42–50